Kovitz Investment Group Partners’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,221,703
Closed -$35.4M 564
2025
Q3
$35.4M Buy
2,221,703
+1,350,767
+155% +$22.3M 0.14% 144
2025
Q2
$15.4M Sell
870,936
-938,403
-52% -$18.3M 0.07% 238
2025
Q1
$37.7M Buy
1,809,339
+594,078
+49% +$11.3M 0.19% 110
2024
Q4
$22.5M Sell
1,215,261
-201,677
-14% -$3.88M 0.11% 160
2024
Q3
$27.8M Buy
+1,416,938
New +$28.2M 0.2% 98

Other funds holding BTAL

Kovitz Investment Group Partners's BTAL Position: Q4 2025 in Review

Kovitz Investment Group Partners sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q4 2025, closing a stake of 2,221,703 shares — an estimated $35.4M sold.

Kovitz Investment Group Partners first reported a position in BTAL in Q3 2024 and held it in 5 quarters. The position peaked at $37.7M in Q1 2025. 81 funds tracked by Wall St. Rank hold BTAL as of Q4 2025.

  • Kovitz Investment Group Partners reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q4 2025 after selling out during the quarter.
  • Kovitz Investment Group Partners sold 2,221,703 AGF US Market Neutral Anti-Beta Fund shares in Q4 2025, an estimated $35.4M.
  • Kovitz Investment Group Partners first reported a position in AGF US Market Neutral Anti-Beta Fund in Q3 2024 and held it in 5 quarters.
  • Kovitz Investment Group Partners's AGF US Market Neutral Anti-Beta Fund position peaked at $37.7M in Q1 2025.
  • 81 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q4 2025.

Based on Kovitz Investment Group Partners's 13F filing for Q4 2025, filed 20 Feb 2026.